Tue 20 Oct 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Updated Section | Month |
|---|---|---|---|
| Gabapentin | Neurontin | 4.6 Fertility, pregnancy and lactation | Nov,2022 |
| Durvalumab | Imfinzi | 4.8. Undesirable effects | Nov,2022 |
| Elasomeran (COVID-19 mRNA vaccine ) | Spikevax | 4.8. Undesirable effects | Nov,2022 |
| Dorzolamide | Trusopt | 4.8 Undesirable effects | Nov,2022 |
| Levothyroxine | Euthyrox | 4.4 Special warnings and precautions for use 4.5 Interaction with other medicinal products and other forms of interaction | Nov,2022 |
| Phenytoin | Accofil | 4.4 Special Warnings and Special Precautions for Use | May,2024 |
| Dabigatran Etexilate Mesylate | Pradaxa | 4.8. Undesirable effects | May,2024 |
| Valproate Sodium | Depakine | 4.6. Fertility, pregnancy and lactation 5.3 Preclinical Safety Data | May, 2026 |
| Methotrexate | Mizotra | 4.6 Fertility, pregnancy and lactation | Mar,2023 |
| Acetylsalicylic Acid | Aspirin® Protect | Drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms | Mar,2023 |
Last update date: 04/10/2026 at 10:24 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.